(2008), "The costs and quality-of-life outcomes of drug-eluting coronary stents: a systematic review", Clinical Governance: An International Journal, Vol. 13 No. 2. https://doi.org/10.1108/cgij.2008.24813bae.006Download as .RIS
Emerald Group Publishing Limited
Copyright © 2008, Emerald Group Publishing Limited
The costs and quality-of-life outcomes of drug-eluting coronary stents: a systematic review
Article Type: Reviews of effectiveness From: Clinical Governance: An International Journal, Volume 13, Issue 2.
P.W. Groeneveld, J.J. Suh and M.A. MattaJournal of Interventional Cardiology2007Vol. 20pp. 1-9
This review assessed differences in quality-of-life (QoL) measures between people who had, or did not have revascularisation procedures following coronary stenting. The authors concluded that there was a QoL benefit in avoiding revascularisation, but also recommended further research. However, since relevant studies might have been missed and it is difficult to assess the reliability of the results, caution is advised.